D. Bebbington

发表

Characterization of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells.

R. Porter, C. Malcolm, K. Benwell, 2000, Free radical biology & medicine.

Hemoglobin H disease and mental retardation: a new syndrome or a remarkable coincidence?

D. Hunt, J. Clegg, D. Weatherall, 1981, The New England journal of medicine.

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

David Bebbington, E. Harrington, C. Demur, 2004, Nature Medicine.

The discovery of the potent aurora inhibitor MK-0457 (VX-680).

David Bebbington, Michael O'Donnell, Damien Fraysse, 2009, Bioorganic & medicinal chemistry letters.

Tributyltin hydride-mediated radical cyclisation of aldehydes and unsaturated ketones: the synthesis of hydroxy tetrahydrofurans, chromanols and related compounds

D. Bebbington, A. Parsons, J. Bentley, 2000 .

A Molecular Brake

David Bebbington, T. Ross Kelly, K. Vijaya Bhaskar, 1994 .

3,5-Disubstituted-4-hydroxyphenyls Linked to 3-Hydroxy-2-methyl- 4(1H)-pyridinone: Potent Inhibitors of Lipid Peroxidation and Cell Toxicity

A. Palmer, C. Malcolm, K. Benwell, 2000 .

ASYMMETRIC TOTAL SYNTHESIS OF THE INDIVIDUAL DIASTEREOISOMERS OF HYPOGLYCIN A

J. Baldwin, R. Adlington, A. Russell, 1995 .

Prodrug and covalent linker strategies for the solubilization of dual-action antioxidants/iron chelators.

J. Spencer, C. Dawson, D. Bebbington, 2002, Bioorganic & medicinal chemistry letters.

Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.

A. Lawrence, R. Gillespie, S. Ward, 2008, Bioorganic & medicinal chemistry letters.

Indoline derivatives as 5-HT(2C) receptor agonists.

G. Kennett, C. Dourish, D. Adams, 2004, Bioorganic & medicinal chemistry letters.

The discovery of the potent aurora inhibitor MK-0457 (VX-680).

M. Mortimore, D. Kay, D. Bebbington, 2009, Bioorganic & medicinal chemistry letters.